Index of reports
> Cases with Cerebral Hypoperfusion (8)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Esidrix (Hydrochlorothiazide) where reactions include cerebral hypoperfusion. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Esidrix side effects in female
Reported by a physician from France on 2012-07-26
Patient: female
Reactions: Cerebral Hypoperfusion, Bradycardia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Levothyroxine Sodium
Administration route: Oral
Indication: Hypothyroidism
Nexium
Administration route: Oral
Esidrix
Administration route: Oral
Indication: Cardiac Failure
Lasix
Administration route: Oral
Indication: Cardiac Failure
Digoxin
Administration route: Oral
Indication: Atrial Fibrillation
End date: 2012-04-17
Sintrom
Dosage: 0.25 df 3 days out of 4
Administration route: Oral
Indication: Atrial Fibrillation
Lyrica
Administration route: Oral
Possible Esidrix side effects in 87 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-25
Patient: 87 year old female
Reactions: Cerebral Hypoperfusion, Bradycardia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lasix
Dosage: long-term therapy.
Administration route: Oral
Nexium
Dosage: long-term therapy.
Administration route: Oral
Sintrom
Dosage: long-term therapy. dose:0.25 unit(s)
Administration route: Oral
Indication: Atrial Fibrillation
Levothyroxine Sodium
Dosage: long-term therapy.
Administration route: Oral
Indication: Hypothyroidism
Digoxin
Dosage: long-term therapy.
Administration route: Oral
Indication: Atrial Fibrillation
End date: 2012-04-17
Lyrica
Dosage: long-term therapy.
Administration route: Oral
Esidrix
Dosage: long-term therapy.
Administration route: Oral
Possible Esidrix side effects in male
Reported by a physician from Canada on 2012-06-06
Patient: male, weighing 61.8 kg (136.0 pounds)
Reactions: Cerebral Hypoperfusion, Hypotension
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Blinded Aliskiren
Dosage: active run in phase
Indication: Cardiovascular Disorder
Blinded NO Treatment Received
Dosage: active run in phase
Indication: Cardiovascular Disorder
Placebo
Dosage: active run in phase
Indication: Cardiovascular Disorder
Esidrix
Dosage: active run in phase
Indication: Cardiovascular Disorder
Hydrochlorothiazide
Dosage: 25 mg, unk
End date: 2011-11-09
Aliskiren
Dosage: 150 mg, unk
Indication: Cardiovascular Disorder
Start date: 2011-10-01
End date: 2011-11-09
Amlodipine
Dosage: 5 mg, unk
Indication: Cardiovascular Disorder
Start date: 2011-10-01
End date: 2011-10-08
Amlodipine
Dosage: active run in phase
Indication: Cardiovascular Disorder
Valsartan
Dosage: 160 mg, qd
Other drugs received by patient: Angiotensin II Antagonists; Aspirin; Atorvastatin Calcium
Possible Esidrix side effects in 87 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-18
Patient: 87 year old female
Reactions: Cerebral Hypoperfusion, Bradycardia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Digoxin
Dosage: 1 df, 1x/day
Administration route: Oral
Indication: Atrial Fibrillation
End date: 2012-04-17
Nexium
Dosage: 20 mg, 1x/day
Administration route: Oral
Esidrix
Dosage: 25 mg, 1x/day
Administration route: Oral
Indication: Cardiac Failure
Levothyroxine Sodium
Dosage: 50 ug, 1x/day
Administration route: Oral
Indication: Hypothyroidism
Lyrica
Dosage: 50 mg, 1x/day
Administration route: Oral
Lasix
Dosage: 40 mg, 1x/day
Administration route: Oral
Indication: Cardiac Failure
Sintrom
Dosage: 0.25 df, 3 days out of 4
Administration route: Oral
Indication: Atrial Fibrillation
Possible Esidrix side effects in female
Reported by a physician from France on 2012-05-18
Patient: female
Reactions: Cerebral Hypoperfusion, Bradycardia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Digoxin
Administration route: Oral
Indication: Atrial Fibrillation
End date: 2012-04-17
Lyrica
Administration route: Oral
Nexium
Administration route: Oral
Esidrix
Administration route: Oral
Indication: Cardiac Failure
Sintrom
Dosage: 0.25 df 3 days out of 4
Administration route: Oral
Indication: Atrial Fibrillation
Levothyroxine Sodium
Administration route: Oral
Indication: Hypothyroidism
Lasix
Administration route: Oral
Indication: Cardiac Failure
Possible Esidrix side effects in 87 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-16
Patient: 87 year old female
Reactions: Cerebral Hypoperfusion, Depressed Level of Consciousness, Bradycardia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Digoxin
Administration route: Oral
Indication: Atrial Fibrillation
End date: 2012-04-17
Lyrica
Administration route: Oral
Levothyroxine Sodium
Administration route: Oral
Indication: Hypothyroidism
Nexium
Administration route: Oral
Sintrom
Dosage: dose:0.25 unit(s)
Administration route: Oral
Indication: Atrial Fibrillation
Esidrix
Administration route: Oral
Lasix
Administration route: Oral
Possible Esidrix side effects in male
Reported by a physician from Canada on 2012-03-02
Patient: male, weighing 61.8 kg (136.0 pounds)
Reactions: Cerebral Hypoperfusion, Hypotension, Vision Blurred
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Aliskiren
Dosage: 150 mg, unk
Indication: Cardiovascular Disorder
Start date: 2011-10-01
End date: 2011-11-09
Hydrochlorothiazide
Dosage: 25 mg, unk
End date: 2011-11-09
Amlodipine
Dosage: 5 mg, unk
Indication: Cardiovascular Disorder
Start date: 2011-10-01
End date: 2011-10-08
Valsartan
Dosage: 160 mg, qd
Blinded Aliskiren
Dosage: active run in phase
Indication: Cardiovascular Disorder
Amlodipine
Dosage: active run in phase
Indication: Cardiovascular Disorder
Esidrix
Dosage: active run in phase
Indication: Cardiovascular Disorder
Placebo
Dosage: active run in phase
Indication: Cardiovascular Disorder
Blinded NO Treatment Received
Dosage: active run in phase
Indication: Cardiovascular Disorder
Other drugs received by patient: Atorvastatin Calcium; Aspirin
Possible Esidrix side effects in male
Reported by a physician from Canada on 2012-02-22
Patient: male, weighing 61.8 kg (136.0 pounds)
Reactions: Cerebral Hypoperfusion, Hypotension
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Blinded NO Treatment Received
Dosage: active run in phase
Indication: Cardiovascular Disorder
Blinded Aliskiren
Dosage: active run in phase
Indication: Cardiovascular Disorder
Valsartan
Dosage: 160 mg, qd
Blinded Placebo
Dosage: active run in phase
Indication: Cardiovascular Disorder
Hydrochlorothiazide
Dosage: 25 mg, unk
Amlodipine
Dosage: active run in phase
Indication: Cardiovascular Disorder
Amlodipine
Dosage: 5 mg, unk
Indication: Cardiovascular Disorder
Start date: 2011-10-01
End date: 2011-10-08
Esidrix
Dosage: active run in phase
Indication: Cardiovascular Disorder
Aliskiren
Dosage: 150 mg, unk
Indication: Cardiovascular Disorder
Start date: 2011-10-01
End date: 2011-11-08
Other drugs received by patient: Atorvastatin; Aspirin
|